# Andes Biotechnologies Global Inc. — Form D

Andes Biotechnologies Global Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-15. The offering totals $15.0M, of which $2.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-12-15
- Form: D
- Accession: 0001725267-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $2.2M
- Remaining: $12.8M
- Investors: 20
- Date of first sale: 2017-11-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-300898

## Issuer

- Name: Andes Biotechnologies Global Inc.
- CIK: 0001725267
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 863 MITTEN ROAD, SUITE 101, BURLINGAME, CA, 94010
- Phone: 56-22367-2000

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Pablo Valenzuela | Director | Burlingame, CA |
| Pablo Valenzuela | Executive Officer | Burlingame, CA |

## More

- [CIK 1725267 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1725267&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001725267-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.